|
⚲
|
| Keyboard |
| Boxer Capital LLC
✚
|
|
|---|---|
| CIK # | 0001465837, 0002018299 |
| CIK | Period |
|---|---|
| 0001465837 0002018299 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| BCTG Acquisition Corp | 0.2 | ||
| Kodiak Sciences Inc | 0.1 | ||
| Revolution Medicines Inc | 0.0 | ||
| Kymera Therapeutics Inc | 0.0 | ||
| Celcuity Inc | 0.0 | ||
| Consonance-HFW Acquisition Corp | 0.0 | ||
| Abivax Sa | 0.0 | ||
| Vaxcyte Inc | 0.0 | ||
| Nile Therapeutics Inc | 0.0 | ||
| Protagonist Therapeutics Inc | 0.0 | ||
| VIR Biotechnology Inc | 0.0 | ||
| Corvus Pharmaceuticals Inc | 0.0 | ||
| Praxis Precision Medicines Inc | 0.0 | ||
| PTC Therapeutics Inc | 0.0 | ||
| Intrexon Corp | 0.0 | ||
| MIND Medicine Mindmed Inc | 0.0 | ||
| Amylyx Pharmaceuticals Inc | 0.0 | ||
| Uniqure NV | 0.0 | ||
| Rexahn Pharmaceuticals Inc | 0.0 | ||
| Corcept Therapeutics Inc | 0.0 | ||
| UroGen Pharma Ltd | 0.0 | ||
| Replimune Group Inc | 0.0 | ||
| UNUM Therapeutics Inc | 0.0 | ||
| Neuralstem Inc | 0.0 | ||
| Glycomimetics Inc | 0.0 | ||
| Allogene Therapeutics Inc | 0.0 | ||
| Cytokinetics Inc | 0.0 | ||
| Contineum Therapeutics Inc | 0.0 | ||
| Prev | Page 1 | Next | |||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001465837] | |
| 3 | [0001465837] | |
| 4 | [0001465837] | |
| SC 13D | [0001465837] | |
| SC 13G | [0001465837] | |
| 13F-HR | [0002018299] | |
| 3 | [0002018299] | |
| 4 | [0002018299] | |
| SC 13G | [0002018299] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tango Therapeutics Inc TNGX
Common Stock
|
2024-11-06 | Sell | 3,080,000 | $3.14 | 9,671,200 |
|
Tango Therapeutics Inc TNGX
Common Stock
|
2024-10-25 | Sell | 633,000 | $6.87 | 4,348,710 |
|
Tango Therapeutics Inc TNGX
Common Stock
|
2024-10-22 | Sell | 250,000 | $6.78 | 1,695,000 |
|
Tango Therapeutics Inc TNGX
Common Stock
|
2024-10-21 | Sell | 625,000 | $7.05 | 4,406,250 |
|
Tyra Biosciences Inc TYRA
Pre-Funded Warrant (right to purchase) · derivative
|
2024-10-18 | Grant | 2,000,000 | ||
|
Tyra Biosciences Inc TYRA
Common Stock
|
2024-10-18 | Disposed to issuer | 2,000,000 | ||
|
iTeos Therapeutics Inc ITOS
Common Stock
|
2024-05-10 | Grant | 1,142,857 | $17.50 | 19,999,998 |
|
Tyra Biosciences Inc TYRA
Common Stock
|
2024-02-06 | Grant | 63,412 | $13.01 | 824,990 |
|
Tyra Biosciences Inc TYRA
Warrant (right to purchase) · derivative
|
2024-02-06 | Grant | 705,280 | $13.01 | 9,175,693 |
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2024-01-23 | Disposed to issuer | 203,754 | ||
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2024-01-23 | Disposed to issuer | 3,135,966 | ||
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2024-01-23 | Disposed to issuer | 3,201,440 | ||
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2024-01-23 | Disposed to issuer | 30,518 | ||
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2024-01-23 | Disposed to issuer | 287,866 | ||
|
Mirati Therapeutics Inc MRTX
Warrant (right to purchase) · derivative
|
2024-01-23 | Disposed to issuer | 332,809 | ||
|
Mirati Therapeutics Inc MRTX
Warrant (right to purchase) · derivative
|
2024-01-23 | Disposed to issuer | 3,578,036 | ||
|
Mirati Therapeutics Inc MRTX
Warrant (right to purchase) · derivative
|
2024-01-23 | Disposed to issuer | 1,413,475 | ||
|
Tango Therapeutics Inc TNGX
Common Stock
|
2023-10-16 | Buy | 500,000 | $6.84 | 3,420,000 |
|
Tango Therapeutics Inc TNGX
Common Stock
|
2023-10-13 | Buy | 750,000 | $7.07 | 5,302,500 |
|
Tango Therapeutics Inc TNGX
Common Stock
|
2023-10-09 | Sell | 50,000 | $9.91 | 495,500 |
| showing 20 of 194 most recent transactions | |||||